FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Heelan

Research Profile

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Co-author Network

Publications

TOP 3
Paul K Paik; Gregory J Riely; Camelia S Sima; Christopher G Azzoli; Robert T Heelan; Leonard P James; Mark G Kris; Vincent A Miller; Erin Moore; Kenneth K Ng; Naiyer A Rizvi
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Katharine A Price; Christopher G Azzoli; Lee M Krug; Maria C Pietanza; Naiyer A Rizvi; William Pao; Mark G Kris; Gregory J Riely; Robert T Heelan; Maria E Arcila; Vincent A Miller
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
Maureen F Zakowski; Sanaa Hussain; William Pao; Marc Ladanyi; Michelle S Ginsberg; Robert T Heelan; Vincent A Miller; Valerie W Rusch; Mark G Kris
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Heelan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Paul K Paik; Gregory J Riely; Camelia S Sima; Christopher G Azzoli; Robert T Heelan; Leonard P James; Mark G Kris; Vincent A Miller; Erin Moore; Kenneth K Ng; Naiyer A Rizvi
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Cancer chemotherapy and pharmacology 2011;68(5):1331-7.
2010: Katharine A Price; Christopher G Azzoli; Lee M Krug; Maria C Pietanza; Naiyer A Rizvi; William Pao; Mark G Kris; Gregory J Riely; Robert T Heelan; Maria E Arcila; Vincent A Miller
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(10):1623-9.
2009: Maureen F Zakowski; Sanaa Hussain; William Pao; Marc Ladanyi; Michelle S Ginsberg; Robert T Heelan; Vincent A Miller; Valerie W Rusch; Mark G Kris
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
Archives of pathology & laboratory medicine 2009;133(3):470-7.
2008: Vincent A Miller; Gregory J Riely; Maureen F Zakowski; Allan R Li; Jyoti D Patel; Robert T Heelan; Mark G Kris; Alan B Sandler; David P Carbone; Anne Tsao; Roy S Herbst; Glenn Heller; Marc Ladanyi; William Pao; David H Johnson
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1472-8.
2008: Naiyer A Rizvi; Gregory J Riely; Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; John Fiore; Gloria Chia; Martin Brower; Robert T Heelan; Michael J Hawkins; Mark G Kris
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):639-43.
2007: Daniel T Milton; Gregory J Riely; Christopher G Azzoli; Jorge Gomez; Robert T Heelan; Mark G Kris; Lee M Krug; William Pao; Barbara Pizzo; Naiyer A Rizvi; Vincent A Miller
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.
Cancer 2007;110(3):599-605.
2007: Lee M Krug; Robert T Heelan; Mark G Kris; Venkatraman E Seshan; Francis M Sirotnak
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(4):317-20.
2007: Michelle S Ginsberg; Ravinder K Grewal; Robert T Heelan
Lung cancer.
Radiologic clinics of North America 2007;45(1):21-43.
2006: David R Gandara; Denise Aberle; Derick H Lau; James Jett; Timothy Akhurst; Robert T Heelan; James Mulshine; Christine Berg; Edward F Patz
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9 Suppl):S20-6.
2006: Daniel T Milton; Gregory J Riely; William Pao; Vincent A Miller; Mark G Kris; Robert T Heelan
Molecular on/off switch.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4940-2.
2006: Daniel T Milton; Christopher G Azzoli; Robert T Heelan; Venkatraman E Seshan; Jorge Gomez; Mark G Kris; Lee M Krug; William Pao; Naiyer A Rizvi; Megan Dunne; Vincent A Miller
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.
Cancer 2006;107(5):1034-41.
2006: Raja M Flores; Lee M Krug; Kenneth E Rosenzweig; Venkatraman E Seshan; Alain Vincent; Robert T Heelan; Timothy Akhurst; Valerie W Rusch
Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(4):289-95.
2005: Lee M Krug; Vincent A Miller; Jyoti Patel; John P Crapanzano; Christopher G Azzoli; Jorge Gomez; Mark G Kris; Robert T Heelan; Barbara Pizzo; Leslie Tyson; Christine Sheehan; Jeffrey S Ross; Venkatraman E Seshan
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
Cancer 2005;104(10):2149-55.
2005: Lee M Krug; John P Crapanzano; Christopher G Azzoli; Vincent A Miller; Naiyer A Rizvi; Jorge Gomez; Mark G Kris; Barbara Pizzo; Leslie Tyson; Megan Dunne; Robert T Heelan
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
Cancer 2005;103(10):2128-31.
2005: Daniel R Brooks; John H M Austin; Robert T Heelan; Michelle S Ginsberg; Victor Shin; Sara H Olson; Joshua Muscat; Steven Stellman
Influence of type of cigarette on peripheral versus central lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(3):576-81.
2005: William Pao; Theresa Y Wang; Gregory J Riely; Vincent A Miller; Qiulu Pan; Marc Ladanyi; Maureen F Zakowski; Robert T Heelan; Mark G Kris; Harold Varmus
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
PLoS medicine 2005;2(1):e17.
2005: Neelam T Shah; Mark G Kris; William Pao; Leslie Tyson; Barbara Pizzo; Murk-Hein Heinemann; Leah Ben-Porat; Dana L Sachs; Robert T Heelan; Vincent A Miller
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):165-74.
2004: William Pao; Vincent A Miller; Maureen F Zakowski; Jennifer Doherty; Katerina Politi; Inderpal S Sarkaria; Bhuvanesh Singh; Robert T Heelan; Valerie W Rusch; Lucinda Fulton; Elaine R Mardis; Doris Kupfer; Richard Wilson; Mark G Kris; Harold Varmus
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(36):13306-11.
2004: Robert T Heelan
Staging and response to therapy of malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2004;45 Suppl 1():S59-61.
2004: Vincent A Miller; Mark G Kris; Neelam Shah; Jyoti Patel; Christopher G Azzoli; Jorge Gomez; Lee M Krug; William Pao; Naiyer A Rizvi; Barbara Pizzo; Leslie Tyson; Venkatraman E Seshan; Leah Ben-Porat; Natalie Memoli; Maureen F Zakowski; Valerie W Rusch; Robert T Heelan
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1103-9.
2003: Carolyn E Reed; David H Harpole; Katherine E Posther; Sandra L Woolson; Robert J Downey; Bryan F Meyers; Robert T Heelan; Homer A Macapinlac; Sin-Ho Jung; Gerard A Silvestri; Barry A Siegel; Valerie W Rusch
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
The Journal of thoracic and cardiovascular surgery 2003;126(6):1943-51.
2003: Vincent A Miller; David H Johnson; Lee M Krug; Barbara Pizzo; Leslie Tyson; Wendy Perez; Peggy Krozely; Alan B Sandler; David Carbone; Robert T Heelan; Mark G Kris; Robert Smith; Judith Ochs
Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2094-100.
2003: David F Yankelevitz; William J Kostis; Claudia I Henschke; Robert T Heelan; Daniel M Libby; Mark W Pasmantier; James P Smith
Overdiagnosis in chest radiographic screening for lung carcinoma: frequency.
Cancer 2003;97(5):1271-5.
2002: Robert J Downey; Kenneth K Ng; Mark G Kris; Manjit S Bains; Vincent A Miller; Robert T Heelan; Mark H Bilsky; Robert J Ginsberg; Valerie W Rusch
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis.
Lung cancer (Amsterdam, Netherlands) 2002;38(2):193-7.
2001: Scott A Laurie; David G Pfister; Mark G Kris; William P Tong; Gregory M Chronowski; Katherine M W Pisters; Robert T Heelan; Francis M Sirotnak
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):501-9.
2000: David H Ilson; Arlene A Forastiere; M Arquette; F Costa; Robert T Heelan; Y Huang; David P Kelsen
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Cancer journal (Sudbury, Mass.) 2000;6(5):316-23.
2000: Lee M Krug; Kenneth K Ng; Mark G Kris; Vincent A Miller; William Tong; Robert T Heelan; L Leon; D Leung; J Kelly; Stefan C Grant; Francis M Sirotnak
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3493-8.
2000: Vincent A Miller; Lee M Krug; Kenneth K Ng; Barbara Pizzo; Wendy Perez; Robert T Heelan; Mark G Kris
Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1346-50.
2000: Vincent A Miller; Kenneth K Ng; Lee M Krug; Wendy Perez; Barbara Pizzo; Robert T Heelan; Mark G Kris
Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.
Cancer 2000;88(5):1045-50.
2000: Lee M Krug; Vincent A Miller; Gregory P Kalemkerian; M J Kraut; Kenneth K Ng; Robert T Heelan; Barbara A Pizzo; Wendy Perez; N McClean; Mark G Kris
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):227-8.
1999: Kenneth K Ng; Mark G Kris; Robert J Ginsberg; Robert T Heelan; Katherine M W Pisters; Vincent A Miller; Stefan C Grant; Manjit S Bains; Valerie W Rusch; Kenneth E Rosenzweig; N Martini
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Cancer 1999;86(7):1189-97.
1999: U Kronawitter; Nancy Kemeny; Robert T Heelan; F Fata; Yuman Fong
Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma.
Cancer 1999;86(2):229-35.
1999: JR Rigas; Mark G Kris; Vincent A Miller; Katherine M W Pisters; Robert T Heelan; Stefan C Grant; DW Fennelly; T C Chou; Francis M Sirotnak
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):601-3.
1999: Robert T Heelan; Valerie W Rusch; Colin B Begg; David M Panicek; James Caravelli; C Eisen
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
AJR. American journal of roentgenology 1999;172(4):1039-47.
1999: Eileen O'Reilly; David H Ilson; Leonard B Saltz; Robert T Heelan; L Martin; David P Kelsen
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.
Cancer investigation 1999;17(3):195-200.
1997: Vincent A Miller; Kenneth K Ng; Stefan C Grant; Hedy L Kindler; Barbara Pizzo; Robert T Heelan; R von Roemeling; Mark G Kris
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1269-71.
1997: Lawrence H Schwartz; David M Panicek; E Thomson; S K Herman; Gaurang V Shah; Robert T Heelan; Yuman Fong; Leslie H Blumgart
Comparison of phased-array and body coils for MR imaging of liver.
Clinical radiology 1997;52(10):745-9.
1997: Robert T Heelan; David M Panicek; ME Burt; James Caravelli; N Martini; Manjit S Bains; PM McCormack; Jason A Koutcher; L Cardini
Magnetic resonance imaging of the postpneumonectomy chest: normal and abnormal findings.
Journal of thoracic imaging 1997;12(3):200-8.
1997: Syed Z Ali; V Hoon; S Hoda; Robert T Heelan; Maureen F Zakowski
Solitary fibrous tumor. A cytologic-histologic study with clinical, radiologic, and immunohistochemical correlations.
Cancer 1997;81(2):116-21.
1997: Harry W Herr; Joel Sheinfeld; H S Puc; Robert T Heelan; Dean F Bajorin; P Mencel; George J Bosl; Robert J Motzer
Surgery for a post-chemotherapy residual mass in seminoma.
The Journal of urology 1997;157(3):860-2.
1997: Vincent A Miller; JR Rigas; William P Tong; J R Reid; Katherine M W Pisters; Stefan C Grant; Robert T Heelan; Mark G Kris
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1997;40(5):415-8.
1996: Katherine M W Pisters; L B Tyson; William Tong; Martin Fleisher; Vincent A Miller; Stefan C Grant; David G Pfister; J R Rigas; C L Densmore; G Krol; Robert T Heelan; Francis M Sirotnak; Joseph R Bertino; Mark G Kris
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1819-24.
1996: H S Puc; Robert T Heelan; Madhu Mazumdar; Harry W Herr; J Scheinfeld; V Vlamis; Dean F Bajorin; George J Bosl; P Mencel; Robert J Motzer
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):454-60.
1996: Edward F Patz; Valerie W Rusch; Robert T Heelan
The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
AJR. American journal of roentgenology 1996;166(2):323-7.
1996: N Martini; Andrew G Huvos; ME Burt; Robert T Heelan; Manjit S Bains; PM McCormack; Valerie W Rusch; M Weber; Robert J Downey; Robert J Ginsberg
Predictors of survival in malignant tumors of the sternum.
The Journal of thoracic and cardiovascular surgery 1996;111(1):96-105; discussion 105-6.
1995: Lawrence H Schwartz; David M Panicek; Jason A Koutcher; Karen T Brown; George I Getrajdman; Robert T Heelan; M Burt
Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Radiology 1995;197(2):421-5.
1995: Vincent A Miller; J R Rigas; Katherine M W Pisters; Stefan C Grant; David G Pfister; Robert T Heelan; Mark G Kris
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
American journal of clinical oncology 1995;18(4):303-6.
1995: David H Ilson; M Sirott; Leonard B Saltz; Robert T Heelan; Y Huang; R Keresztes; David P Kelsen
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Cancer 1995;75(9):2197-202.
1995: Lawrence H Schwartz; David M Panicek; Jason A Koutcher; Robert T Heelan; Manjit S Bains; M Burt
Echoplanar MR imaging for characterization of adrenal masses in patients with malignant neoplasms: preliminary evaluation of calculated T2 relaxation values.
AJR. American journal of roentgenology 1995;164(4):911-5.
1995: David M Panicek; Lawrence H Schwartz; Robert T Heelan; James Caravelli
Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm.
Skeletal radiology 1995;24(3):185-90.
1995: Mark G Kris; Katherine M W Pisters; Robert J Ginsberg; J R Rigas; Vincent A Miller; Stefan C Grant; R J Gralla; Robert T Heelan; N Martini
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S47-57.
1995: Vincent A Miller; J R Rigas; P A Francis; Stefan C Grant; Katherine M W Pisters; Venkatraman E Seshan; K Woolley; Robert T Heelan; Mark G Kris
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.
Cancer 1995;75(4):968-72.
1994: R C Marcove; Robert T Heelan; B Lindeque; John Healey; G Rosen
Treatment of a second bone osteosarcoma. 3 cases and an unusual MRI finding.
Acta orthopaedica Scandinavica 1994;65(4):480-2.
1994: Robert T Heelan; L N Rothenberg; James Caravelli; R C Fleischman; RA Castellino
Low-density supradiaphragmatic band artifact on advanced multiple-beam equalization radiography of the chest.
Investigative radiology 1994;29(8):777-80.
1994: Robert T Heelan
CT and MR imaging in the evaluation of pleural masses.
Chest surgery clinics of North America 1994;4(3):431-50.
1994: P A Francis; J R Rigas; Mark G Kris; Katherine M W Pisters; J P Orazem; K J Woolley; Robert T Heelan
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1232-7.
1994: M Burt; Robert T Heelan; Daniel G Coit; PM McCormack; Manjit S Bains; N Martini; Valerie W Rusch; Robert J Ginsberg
Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
The Journal of thoracic and cardiovascular surgery 1994;107(2):584-8; discussion 588-9.
1994: Ephraim S Casper; M R Green; David P Kelsen; Robert T Heelan; T D Brown; Carlos D Flombaum; B Trochanowski; P G Tarassoff
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.
Investigational new drugs 1994;12(1):29-34.
1993: RP Warrell; D Lovett; F A Dilmanian; R Schneider; Robert T Heelan
Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2443-50.
1993: B S Reichman; Andrew D Seidman; John Crown; Robert T Heelan; Tzy-Jyun Yao; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.
Annals of the New York Academy of Sciences 1993;698():398-402.
1993: W Richard Webb; M Sarin; Robert Harriman; Robert T Heelan; G M Glazer; C Gatsonis
Interobserver variability in CT and MR staging of lung cancer.
Journal of computer assisted tomography 1993;17(6):841-6.
1993: B S Reichman; Andrew D Seidman; John Crown; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie; Clifford Hudis
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1943-51.
1993: Katherine M W Pisters; Mark G Kris; R J Gralla; M B Zaman; Robert T Heelan; N Martini
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1757-62.
1993: Valerie W Rusch; Homer A Macapinlac; Robert T Heelan; E Kramer; Steven M Larson; P McCormack; M Burt; N Martini; Robert J Ginsberg
NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.
The Journal of thoracic and cardiovascular surgery 1993;106(2):200-4.
1993: Andrew D Seidman; Larry Norton; B S Reichman; John Crown; Tzy-Jyun Yao; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.
Seminars in oncology 1993;20(4 Suppl 3):40-5.
1993: N Martini; Mark G Kris; B J Flehinger; R J Gralla; Manjit S Bains; ME Burt; Robert T Heelan; PM McCormack; Katherine M W Pisters; J R Rigas
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
The Annals of thoracic surgery 1993;55(6):1365-73; discussion 1373-4.
1993: A Kritz; John Crown; Robert J Motzer; Lilian Reich; Glenn Heller; M P Moore; N Hamilton; Tzy-Jyun Yao; Robert T Heelan; J G Schneider
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Cancer 1993;71(8):2515-21.
1993: J Baselga; Mark G Kris; Howard I Scher; M Phillips; Robert T Heelan
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Investigational new drugs 1993;11(1):85-6.
1993: Andrew D Seidman; B S Reichman; John Crown; Tzy-Jyun Yao; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.
Journal of the National Cancer Institute. Monographs 1993;(15):171-5.
1992: John T Vetto; Robert T Heelan; M Burt
Malignant melanoma metastatic to the right atrium: an asymptomatic solitary metastasis diagnosed incidentally by magnetic resonance imaging.
The Journal of thoracic and cardiovascular surgery 1992;104(3):843-4.
1992: David P Kelsen; O T Atiq; Leonard B Saltz; D Niedzwiecki; D Ginn; D Chapman; Robert T Heelan; C Lightdale; V Vinciguerra; Murray F Brennan
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):541-8.
1992: L Kostakoglu; Samuel D J Yeh; Carol S Portlock; Robert T Heelan; Tzy-Jyun Yao; D Niedzwiecki; Steven M Larson
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(3):345-50.
1992: David P Kelsen; D Lovett; J Wong; Leonard B Saltz; M Buckley; P Murray; Robert T Heelan; C Lightdale
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):269-74.
1991: David M Panicek; Ephraim S Casper; Murray F Brennan; S I Hajdu; Robert T Heelan
Hemorrhage simulating tumor growth in malignant fibrous histiocytoma at MR imaging.
Radiology 1991;181(2):398-400.
1991: T A Steffens; Dean F Bajorin; Paul B Chapman; D R Lovett; B V Cody-Johnson; M A Templeton; Robert T Heelan; G Y Wong; Carol S Portlock; H F Oettgen
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Cancer 1991;68(6):1230-7.
1991: R C Marcove; Robert T Heelan; Andrew G Huvos; John Healey; B G Lindeque
Osteoid osteoma. Diagnosis, localization, and treatment.
Clinical orthopaedics and related research 1991;(267):197-201.
1991: John Crown; S Gulati; David J Straus; Jonathan E Kolitz; Robert T Heelan; J O'Brien; B J Lee; Carol S Portlock; J Bertino
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas.
Investigational new drugs 1991;9(2):185-6.
1991: J R Rigas; Mark G Kris; R J Gralla; Robert T Heelan; L D Marks
Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.
Investigational new drugs 1991;9(2):187-90.
1991: Robert T Heelan
Lung cancer imaging: primary diagnosis, staging, and local recurrence.
Seminars in oncology 1991;18(2):87-98.
1991: M Z Berger; Mark G Kris; R J Gralla; L D Marks; L M Potanovich; J J Dimaggio; Robert T Heelan
Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.
American journal of clinical oncology 1991;14(2):124-6.
1991: W Richard Webb; C Gatsonis; Robert Harriman; Robert T Heelan; G M Glazer; Isaac R Francis; B J McNeil
CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
Radiology 1991;178(3):705-13.
1990: Jason A Koutcher; Douglas Ballon; M Graham; John Healey; E S Casper; Robert T Heelan; L E Gerweck
31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1990;16(1):19-34.
1990: G C Toner; David M Panicek; Robert T Heelan; N L Geller; S Y Lin; Dean F Bajorin; Robert J Motzer; Howard I Scher; Harry W Herr; M J Morse
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1683-94.
1990: D Ginn; David P Kelsen; Mario A Eisenberger; Robert T Heelan; G Magill
Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach.
Investigational new drugs 1990;8(3):321-4.
1990: David P Kelsen; Bruce D Minsky; M Smith; J Beitler; D Niedzwiecki; D Chapman; Manjit S Bains; M Burt; Robert T Heelan; B Hilaris
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1352-61.
1990: David M Panicek; G C Toner; Robert T Heelan; George J Bosl
Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Radiology 1990;175(2):499-502.
1989: Robert T Heelan; B E Demas; James Caravelli; N Martini; Manjit S Bains; PM McCormack; M Burt; David M Panicek; A Mitzner
Superior sulcus tumors: CT and MR imaging.
Radiology 1989;170(3 Pt 1):637-41.
1989: Mark G Kris; R W D'Acquisto; R J Gralla; M T Burke; L D Marks; M P Fanucchi; Robert T Heelan
Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.
American journal of clinical oncology 1989;12(1):24-6.
1988: S C Brennan; William H Redd; Paul B Jacobsen; O Schorr; Robert T Heelan; G K Sze; G Krol; B E Peters; J K Morrissey
Anxiety and panic during magnetic resonance scans.
Lancet 1988;2(8609):512.
1988: J Frame; David P Kelsen; Nancy Kemeny; E Cheng; D Niedzwiecki; Robert T Heelan; R Lippermann
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
American journal of clinical oncology 1988;11(4):490-5.
1988: B E Demas; Robert T Heelan; J Lane; R Marcove; S Hajdu; Murray F Brennan
Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease.
AJR. American journal of roentgenology 1988;150(3):615-20.
1988: K Y Shum; Mark G Kris; R J Gralla; M T Burke; L D Marks; Robert T Heelan
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(3):446-50.
1988: Howard I Scher; R Gralla; L Linares; Mark G Kris; Robert T Heelan; B Shank
Preliminary results of combination chemotherapy and sequential accelerated fractionation radiation therapy in limited-stage small cell carcinoma of the lung. Evaluation of measures for reduction of toxicity and effect on complete response rate.
Antibiotics and chemotherapy 1988;41():184-9.
1987: Robert T Heelan; Manjit S Bains; S Yeh
Medical imaging in lung cancer.
The Surgical clinics of North America 1987;67(5):1015-23.
1987: Robert T Heelan; B S Hilaris; L L Anderson; D Nori; N Martini; R C Watson; James Caravelli; L A Linares
Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning.
Radiology 1987;164(3):735-40.
1987: Robert J Motzer; George J Bosl; Robert T Heelan; W Fair; W Whitmore; Pramod C Sogani; Harry W Herr; M Morse
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1064-70.
1987: Mark G Kris; R J Gralla; M T Burke; J J Fiore; David P Kelsen; L D Marks; Robert T Heelan
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):783-4.
1987: Mark G Kris; R J Gralla; M T Burke; L D Berkowitz; L D Marks; David P Kelsen; Robert T Heelan
Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):763-4.
1987: David P Kelsen; J Buckner; A Einzig; G Magill; Robert T Heelan; V Vinciguerra
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1987;71(3):329-30.
1987: David P Kelsen; J Fiore; Robert T Heelan; E Cheng; G Magill
Phase II trial of etoposide in APUD tumors.
Cancer treatment reports 1987;71(3):305-7.
1986: J P O'Connell; Mark G Kris; R J Gralla; S Groshen; A Trust; J J Fiore; David P Kelsen; Robert T Heelan; R B Golbey
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1604-14.
1986: Dean F Bajorin; David P Kelsen; Robert T Heelan
Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.
Cancer treatment reports 1986;70(10):1245-6.
1986: Mark G Kris; R J Gralla; Michael S Wertheim; David P Kelsen; J P O'Connell; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1986;70(9):1091-6.
1986: Robert Harriman; F P Stitik; Stanley S Siegelman; D P Naidich; S S Sagel; A V Proto; J R Muhm; J W Walsh; C R Martinez; Robert T Heelan
CT of the pulmonary nodule: a cooperative study.
Radiology 1986;160(2):319-27.
1986: David P Kelsen; R Fein; C Coonley; Robert T Heelan; Manjit S Bains
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Cancer treatment reports 1986;70(2):255-9.
1985: A Einzig; David P Kelsen; E Cheng; P Sordillo; Robert T Heelan; R Winn; G Magill
Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1985;69(12):1453-4.
1985: N Martini; Robert T Heelan; J Westcott; Manjit S Bains; P McCormack; James Caravelli; R Watson; M Zaman
Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma.
The Journal of thoracic and cardiovascular surgery 1985;90(5):639-48.
1985: C Sternberg; David P Kelsen; M Dukeman; L Leichman; Robert T Heelan
Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Cancer treatment reports 1985;69(11):1305-7.
1985: Mark G Kris; R J Gralla; David P Kelsen; E S Casper; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
American journal of clinical oncology 1985;8(5):377-9.
1985: Robert T Heelan; N Martini; J W Westcott; Manjit S Bains; R C Watson; James Caravelli; Y M Berkmen; Claudia I Henschke; PM McCormack; B C McCaughan
Carcinomatous involvement of the hilum and mediastinum: computed tomographic and magnetic resonance evaluation.
Radiology 1985;156(1):111-5.
1985: D M Mintzer; David P Kelsen; D Frimmer; Robert T Heelan; R Gralla
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
Cancer treatment reports 1985;69(6):711-2.
1985: Mark G Kris; R J Gralla; L A Kalman; David P Kelsen; E S Casper; M T Burke; S Groshen; I R Cibas; R Bagin; Robert T Heelan
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Cancer treatment reports 1985;69(4):387-95.
1985: Mark G Kris; R J Gralla; David P Kelsen; E S Casper; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Chest 1985;87(3):368-72.
1985: Robert T Heelan; D B Louria; M K Rosenblum
Fever and jaundice in a 27-year-old woman with acute myelomonocytic leukemia.
Cancer investigation 1985;3(3):261-70.
1984: B J Flehinger; M R Melamed; M B Zaman; Robert T Heelan; W B Perchick; N Martini
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study.
The American review of respiratory disease 1984;130(4):555-60.
1984: M R Melamed; B J Flehinger; M B Zaman; Robert T Heelan; W A Perchick; N Martini
Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York.
Chest 1984;86(1):44-53.
1984: Robert T Heelan; B J Flehinger; M R Melamed; M B Zaman; W B Perchick; James Caravelli; N Martini
Non-small-cell lung cancer: results of the New York screening program.
Radiology 1984;151(2):289-93.
1983: David P Kelsen; B Hilaris; C Coonley; Robert A Chapman; M Lesser; M Dukeman; Robert T Heelan; Manjit S Bains
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
The American journal of medicine 1983;75(4):645-52.
1983: David P Kelsen; Robert T Heelan; C Coonley; Manjit S Bains; N Martini; B Hilaris; R B Golbey
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
American journal of clinical oncology 1983;6(5):539-46.
1983: L A Kalman; Mark G Kris; R J Gralla; David P Kelsen; E S Casper; Robert T Heelan; R E Wittes
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Cancer treatment reports 1983;67(6):591-2.
1983: David P Kelsen; G B Magill; E Cheng; M Dukeman; P Sordillo; Robert T Heelan; A Yagoda
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1983;67(5):509-10.
1983: C J Coonley; Manjit S Bains; Robert T Heelan; M Dukeman; David P Kelsen
Phase II study of etoposide in the treatment of esophageal carcinoma.
Cancer treatment reports 1983;67(4):397-8.
1983: L M Itri; R J Gralla; David P Kelsen; Robert A Chapman; E S Casper; D W Braun; J E Howard; R Golbey; Robert T Heelan
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Cancer 1983;51(6):1050-5.
1982: David P Kelsen; Robert A Chapman; Manjit S Bains; Robert T Heelan; M Dukeman; R Golbey
Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Cancer treatment reports 1982;66(6):1427-9.
1982: J Smith; Robert T Heelan; A G Huvos; B Caparros; G Rosen; C Urmacher; James Caravelli
Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients.
Radiology 1982;143(2):355-60.
1981: H J Flehinger; M R Melamed; M B Zaman; Robert T Heelan; W Perchick; N Martini
Resectability of lung cancer and survival in the New York Lung Cancer Detection Program.
World journal of surgery 1981;5(5):681-7.
1981: M R Melamed; B J Flehinger; M B Zaman; Robert T Heelan; E T Hallerman; N Martini
Detection of true pathologic stage I lung cancer in a screening program and the effect on survival.
Cancer 1981;47(5 Suppl):1182-7.
1981: Robert T Heelan; D A Filippa
Lymphoma of kidney mimicking simple renal cyst on ultrasound.
Clinical bulletin 1981;11(3):139-41.
1980: Robert T Heelan; M R Melamed; M B Zaman; N Martini; B J Flehinger
Radiologic diagnosis of oat cell cancer in a high-risk screened population.
Radiology 1980;136(3):593-601.
1979: Robert T Heelan; R C Watson; J Smith
Computed tomography of lower extremity tumors.
AJR. American journal of roentgenology 1979;132(6):933-7.
1978: B J Flehinger; M R Melamed; Robert T Heelan; C M McGinnis; M B Zaman; N Martini
Accuracy of chest film screening by technologists in the New York early lung cancer detection program.
AJR. American journal of roentgenology 1978;131(4):593-7.
1978: L Weis; Robert T Heelan; R C Watson
Computed tomography of orthopedic tumors of the pelvis and lower extremities.
Clinical orthopaedics and related research 1978;(130):254-9.
1977: Robert T Heelan; D L Mullen
Acute peripheral consolidation of the lung.
Clinical bulletin 1977;7(2):70-1.